Blood Research

Cited by CrossRef (5)

  1. Seigi Oshima, Shojiro Inano, Toshiyuki Kitano. Epstein-Barr-Virus-Related Lymphoproliferative Disorder in a Patient With Primary Myelofibrosis: A Case Report and Literature Review. 2024
    https://doi.org/10.7759/cureus.56586
  2. Pierre‐Luc Mouchel, Charlotte Syrykh, Camille Laurent, Suzanne Tavitian, Martin Gauthier. First case of classical Hodgkin‐like EBV‐positive lymphoproliferative disorder under ruxolitinib therapy. American J Hematol 2021;96:755
    https://doi.org/10.1002/ajh.26026
  3. Marissa Sjoblom, Haithem Chtioui, Montserrat Fraga, Gregoire Stalder, Francesco Grandoni, Sabine Blum. Hepatitis B reactivation during ruxolitinib treatment. Ann Hematol 2022;101:2081
    https://doi.org/10.1007/s00277-022-04851-6
  4. Bianca Puello Yocum, Hector Mesa, Jennifer K. Maratt, Aaron C. Ermel, Naveen Manchanda, Nikolay Popnikolov. EBV-Gastritis Preceded the Development of Nasopharyngeal EBV (+) Diffuse Large B Cell Lymphoma in a Patient With Ruxolitinib-Induced Immunosuppression. Int J Surg Pathol 2023;31:1340
    https://doi.org/10.1177/10668969221137525
  5. . Ruxolitinib. Reactions Weekly 2020;1795:244
    https://doi.org/10.1007/s40278-020-76265-x
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd